PATENT CLAIM ANALYSIS

Application Number: 16009751
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "161000"]

Abstract:
The present invention relates to a method of reducing or preventing the symptoms associated with the common cold. The method comprises administering to a subject an effective amount of a pharmaceutical composition before presenting with at least one symptom of the common cold. The pharmaceutical composition comprises a non-steroidal anti-inflammatory drug and a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, salts thereof, and combinations thereof.

Claim (Index 10):
The method of  claim 2  wherein the amount of ibuprofen is about 200 mg to about 800 mg.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 94.0
- Lexical Diversity: 1.55102
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15074524', '14699676', '11172878', '10363430', '13503097']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7685070480613065
- 35 USC 102 Novelty (BERT): 0.5014388054057967
- Combined Prediction Score: 0.7418002237957555
- Mean Citation Score: 211.190474
- Max Citation Score: 239.92516
- Similarity Product: 169.01675462931868

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test